Previous 10 | Next 10 |
BiondVax Provides Update at Biomed Israel Conference and Announces Significant Progress in its Nanosized Antibodies Program PR Newswire JERUSALEM , May 12, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) , a biopharmaceutical com...
BiondVax to Present at this week's Biomed Israel Conference PR Newswire JERUSALEM , May 9, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovati...
BiondVax to host a Hebrew-language analyst and investor webinar on April 6th PR Newswire JERUSALEM , April 5, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializi...
BiondVax Pharmaceuticals Ltd. (BVXV) Q4 2021 Earnings Conference Call April 04, 2022 10:00 AM ET Company Participants Kenny Green - Edison Group, IR Josh Phillipson - Director of Business Development and Investor Relations Amir Reichman - Chief Executive Officer Matthias Dobbelstein - Profess...
BiondVax to host analyst and investor webinar on April 4th PR Newswire JERUSALEM , March 31, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative pro...
Clever Leaves Holdings (CLVR) -20% after sharp rally last week. Companhia Energetica (CIG) -15%. BiondVax Pharmaceuticals (BVXV) -9% on FY earnings release. Enservco (ENSV) -8% announces to amend its Financial Statements for First, Second and Third Quarters of 2021. Indone...
Biondvax Pharmaceuticals press release (NASDAQ:BVXV): FY GAAP EPS of -NIS0.07. As of December 31, 2021, cash and cash equivalents of NIS 54 million as compared to NIS 9.4 million as of December 31, 2020. Shares -8.99% PM For further details see: Biondvax Pharmaceuticals G...
BiondVax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update PR Newswire JERUSALEM , March 28, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufac...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apple (NASDAQ: AAPL ) stock is on the move Thursday as investors react to a positive price target for the company’s shares. Source: ZorroGabriel / Shutterstock.com Wedbush analyst Daniel Ives is behind ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips BiondVax (NASDAQ: BVXV ) stock is a big mover today, soaring on news of an antibody development agreement. As of this writing, BVXV stock has gained more than 26% as investors price in this catalyst. Source: Shutte...
News, Short Squeeze, Breakout and More Instantly...
BiondVax Pharmaceuticals Ltd. Company Name:
BVXV Stock Symbol:
NASDAQ Market:
BiondVax (NASDAQ: BVXV) , a biotechnology company, today announced a change of its corporate name to Scinai Immunotherapeutics, which will debut on the Nasdaq under a new symbol, SCNI, on Sept. 7, 2023. In the past two years, the company has revamped its senior management team and pharmaceuticals...
JERUSALEM, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) , a biopharmaceutical company, is pleased to announce today a change of its corporate name to Scinai Immunotherapeutics Ltd. (“Scinai ”). In the past two years, the Company ...
BiondVax (NASDAQ: BVXV) , a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized antibodies (“NanoAbs”) targeting IL-17 cytokines as treatments for psoriasis and psoriatic arthritis, recently recei...